Acetylcholine primarily acts on muscarinic receptors in the parasympathetic nervous system to mediate its effects.
Beta-blockers reduce blood pressure by decreasing heart rate and cardiac output, thus lowering overall workload on the heart.
Short-acting beta-agonists like albuterol are the first-line treatment for acute asthma attacks due to their rapid bronchodilatory effects.
Aminoglycosides are associated with nephrotoxicity and ototoxicity, which are significant concerns during therapy.
Direct thrombin inhibitors like dabigatran bind directly to thrombin and prevent clot formation.
SSRIs are primarily used to treat depression by increasing serotonin levels in the synaptic cleft.
